CClinicalTrials.gg
CompletedNCT02655497Updated Nov 18, 2016

Maintaining Independence in Everyday Life Among Seniors With Subjective Cognitive Complaints

An interventional study of Cognitive training and Psychosocial education in Aging, sponsored by Baycrest. Completed at 1 site in Canada. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-11-18.

Sponsored by Baycrest · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine the effectiveness of cognitive strategies in improving participation in daily activities within older adults who report subjective cognitive decline.

Read the detailed description

The planned project explores the effects of several interventions designed to promote independence in everyday life, with older adults who identify cognitive complaints. Evidence suggests that 25-50% of community dwelling older adults report cognitive difficulties, such as reduced memory or concentration, in the absence of any diagnosed condition. Cognitive skills are crucial to living independently. The investigators plan to examine two approaches in a randomized controlled trial. Based on our successful pilot study, the investigators hypothesize that this training which combines education on healthy lifestyles and problem solving training to address everyday life difficulties, will be effective in maximizing and maintaining independence of older adults.

02

Conditions studied

  • Aging
03

In context

Lead sponsor

Baycrest is the lead sponsor of 33 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Community-dwelling older adults aged 60+
  • Fluent in written and spoken English
  • Have subjective cognitive complaints (SCC)
  • Performance within normal limits on a neuropsychological assessment battery
  • Participants must also be able to self-identify specific areas of difficulty in their everyday life that they would like to improve

Exclusion criteria

Exclusion Criteria:

  • Significant neurological or psychiatric history (e.g., multiple sclerosis, psychiatric illness requiring hospitalization)
  • Concurrent depression
  • Anaesthesia in previous 6 months; and substance abuse
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
16 participants (actual)

Study arms

  • Experimental
    Cognitive Training

    Cognitive training intervention. The intervention includes seven 2-hour group sessions interspersed with four individual 45-minute sessions for a total of 17 hours of intervention over an 8-week period. The experimental group will receive real-world strategy training, a cognitive strategy based approach that trains people to improve their level of independence on meaningful activities of daily life with which they are having difficulty.

    Behavioral: Cognitive training

  • Active comparator
    Psychosocial education

    The intervention includes seven 2-hour group sessions interspersed with four individual 45-minute sessions for a total of 17 hours of intervention over an 8-week period. The control group will receive brain-health education.

    Behavioral: Psychosocial education

Interventions

  • BehavioralCognitive training
  • BehavioralPsychosocial education
06

What researchers measure

Primary outcomes

  1. Change in the Canadian Occupational Performance Measure (COPM) scores

    The Canadian Occupational Performance Measure (COPM) is the primary outcome measure. All participants will identify five everyday life activities that they need to or want to do using the COPM. The primary outcome will be (a) the number of goals improved by two points.

    Time frame: 8 weeks after pretest and 3 months after intervention finished

07

Study locations

1 site
  • Baycrest Health Sciences
    Toronto, Ontario M6A 2E1, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02655497
Lead sponsor
Baycrest
Collaborators
Canadian Institutes of Health Research (CIHR)
Responsible party
Dr. Deirdre Dawson (Senior Scientist, Baycrest) — Principal investigator
First posted
Jan 14, 2016
Start date
Sep 2015
Primary completion
Aug 2016
Completion
Sep 2016
Last update
Nov 18, 2016

Study contacts

Deirdre Dawson, PhD
principal investigator · Baycrest Health Sciences

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion